ReviewNature protocols2026
Identification of immunogenic commensal antigens using phage display.
Review in Nature protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Humoral immunity plays a major role in the establishment and maintenance of host-microbiota commensalism and immunity to pathogenic microorganisms. However, identification of antigens eliciting adaptive immune responses within barrier and systemic tissues represents a significant hurdle to further understanding this host-microbe dialogue. Here, we provide a protocol to identify immunogenic protein antigens expressed by commensal and pathogenic microbes by using bacteriophage (phage) display-mediated antibody/antigen biopanning. The procedure entails generation of an M13-phagemid library, production of an ORFeome (totality of open reading frames) phage library followed by multiple rounds of affinity-based immunoprecipitation and subsequent antigen validation by ELISA, ELISPOT and/or B cell tetramer generation. The protocol is optimized to identify antigens eliciting both IgA and IgG isotype responses and can use either circulating or intestinal antibodies for antigen identification. Generation and isolation of monoclonal phage encoding putative protein antigens enable simple identification of immunogenic antigens by Sanger sequencing, often providing protein domain-level resolution of epitope-bearing regions. Our protocol can be carried out by a trained molecular biologist and enables antigen identification and validation in the timeframe of weeks.
Indexed as
Identifiers
40528087What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.